Middleweight prospect Adam Hunter, who was supposed to make his Octagon debut against Ryan Janes at UFC on Fox 21 before being flagged for a potential anti-doping violation, was handed a two-year suspension on Friday.
USADA and the British Columbia Athletic Commission (BCAC) announced that Hunter failed a pre-fight out-of-competition drug test and tested positive for amoxifen metabolite, boldenone metabolites, methandienone metabolites, clenbuterol and drostanolone metabolites, all of which are banned substances.
Because of the wide spectrum of illegal substance found in Hunter’s sample, he has received a two-year sanction, retroactive to Aug. 26, 2016. The Canadian fighter will not be eligible to return to MMA until Aug. 28, 2018.
The release reads as follows:
“These non-specified substances are prohibited at all times under the BCAC Anti-Doping Policy and the UFC Anti-Doping Policy, both of which have adopted the World Anti-Doping Agency (WADA) Prohibited List. On the WADA Prohibited List, tamoxifen is a substance in the class of Hormone and Metabolic Modulators, while boldenone, methandienone, drostanolone, and clenbuterol are substances in the class of Anabolic Agents.
“Under the UFC Anti-Doping Policy, the standard sanction for an anti-doping policy violation involving a non-specified substance is a two-year period of ineligibility.”